- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Malignant Melanoma, Skin in United Kingdom
Total 25094 results
-
SanofiActive, not recruitingMalignant Melanoma | Squamous Cell Carcinoma of SkinGermany, Spain, France, Chile, United States, Australia, Italy
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMalignant MelanomaUnited States
-
CelgeneNYU Langone Health; Syneos Health; Celerion; ApoCell, Inc.CompletedMalignant MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Gene Vector LaboratoryCompletedMalignant MelanomaUnited States
-
James Graham Brown Cancer CenterUniversity of LouisvilleCompleted
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysTerminated
-
Eli Lilly and CompanyMemorial Sloan Kettering Cancer CenterCompleted
-
NeoPlas InnovationWithdrawnMelanoma | Malignant MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaItaly, United Kingdom, Belgium, Poland, Netherlands, Germany, Austria, Czechia, Ireland, Sweden
-
Mt. Sinai Medical Center, MiamiBayer; Chiron CorporationCompletedMalignant MelanomaUnited States
-
St. Jude Children's Research HospitalSchering-PloughActive, not recruitingMalignant MelanomaUnited States
-
Lokon Pharma ABPrecision Oncology LLCCompletedMalignant MelanomaSweden, United States
-
Columbia UniversityMerck Sharp & Dohme LLCTerminated
-
Northern California Melanoma CenterBayer; Melanoma Research InstituteCompleted
-
Titan PharmaceuticalsTerminated
-
Mt. Sinai Medical Center, MiamiBayer; Celgene CorporationCompletedMalignant MelanomaUnited States
-
Immunocore LtdAstraZenecaCompletedMalignant MelanomaUnited States
-
Craig L Slingluff, JrNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Malignant Conjunctival Neoplasm | Melanoma (Skin)United States
-
Northern California Melanoma CenterPfizer; Schering-PloughTerminated
-
SciBase ABCompleted
-
Gradalis, Inc.CompletedMelanoma | Malignant Melanoma | Melanoma RecurrentUnited States
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
Bristol-Myers SquibbCompletedMalignant MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance, Germany, Italy, Sweden, United States, Australia, Canada, United Kingdom, Netherlands, Switzerland, New Zealand, Israel
-
Lynn E. Spitler, MDUniversity of California, San FranciscoCompletedMalignant Melanoma, MetastaticUnited States
-
Regeneron PharmaceuticalsCompleted
-
Clavis PharmaCompletedMalignant MelanomaUnited States, Sweden, Norway
-
TransMolecularTerminatedMelanoma | Metastatic Melanoma | Malignant MelanomaUnited States
-
Baylor Research InstituteTerminatedMalignant Melanoma Stage IVUnited States
-
AstraZenecaCompleted
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States
-
Bristol-Myers SquibbMedarex; Ono Pharma USA IncCompleted
-
National Cancer Institute (NCI)Active, not recruitingStage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Lentigo Maligna Melanoma | Mucosal Melanoma | Acral Lentiginous Melanoma | Cutaneous Nodular Melanoma | Low-CSD MelanomaUnited States
-
Ultimovacs ASAActive, not recruitingMalignant MelanomaUnited States
-
Orlucent, IncUniversity Hospitals, Leicester; NHS Tayside; University of Dundee; NHS Greater... and other collaboratorsCompletedMelanoma | Skin Lesion | MolesUnited Kingdom
-
Genentech, Inc.Completed
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingClinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Pathologic Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIA Cutaneous Melanoma...United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); University of Pennsylvania; RTI International; ITX CorporationCompletedMelanoma and Other Malignant Neoplasms of SkinUnited States
-
Baylor Research InstituteCompletedMalignant Melanoma Stage IVUnited States
-
Roswell Park Cancer InstituteCompletedStage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin Melanoma | Stage IB Skin MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Ahmad TarhiniNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Malignant Conjunctival Neoplasm | Melanoma (Skin)United States
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Acral Lentiginous Malignant MelanomaUnited States
-
St. Louis UniversityCompletedMelanoma | Metastatic Melanoma | Stage IV Melanoma | Unresectable Malignant Neoplasm | Stage III MelanomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin MelanomaUnited States
-
Hoffmann-La RocheCompleted
-
Genentech, Inc.CompletedMalignant MelanomaUnited States, Australia
-
Immuneering CorporationRecruitingPancreatic Adenocarcinoma | Advanced Solid Tumor | Non-small Cell Lung Cancer (NSCLC) | Malignant Melanoma (Cutaneous)United States
-
Immodulon Therapeutics LtdCompletedMelanomaUnited Kingdom